ERYtech Pharma To Hold Full-Year 2015 Business Update Conference Call On February 24, 2016
LYON, France--(BUSINESS WIRE)--Regulatory News:
ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company developing innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, today announced that it will release its financial results and business update for the year ended December 31, 2015 on Tuesday, February 23, 2016 after the close of trading on the Euronext Paris.
ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company developing innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, today announced that it will release its financial results and business update for the year ended December 31, 2015 on Tuesday, February 23, 2016 after the close of trading on the Euronext Paris.